ncRNA name
MALAT1
Specific or universal ncRNAs
Universal ncRNAs
Class
Long noncoding RNA
Biomarker
None
Biomarker application
Upstream regulatory factors
Not available
Downstream target
miR-22-3p
Cancer name
Gastric Cancer
Cancer site
qRT-PCR,Western blot,Luciferase assay
Treatment type
Chemotherapy
Drug
Oxaliplatin
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
MALAT1 modulates ZFP91 to promote GC cells OXA resistance via sponging miR-22-3p
Tissue resource
gastric cancer tissues and normal tumor-adjacent tissuesZhangye People's Hospital Affiliated to Hexi University
normal cell lines GES-1
gastric cancer cell lines SGC-7901
gastric cancer cell lines BGC-823
gastric cancer oxaliplatin-resistant cell lines SGC-7901/OXA
gastric cancer oxaliplatin-resistant cell lines BCG-823/OXA
Experiment
None
Institute
RiboBio Co
Country
China
China
Continent
Asia
Asia